Owing to that after weight reduction, adiponectin increases, improving insulin sensitivity throughout the body [9-12], its plasmatic concentration has been proposed as a candidate biomarker to identify metabolic alterations including those of MetS [13-15]. The gene discussed is INS; the disease is metabolic syndrome.